Stay updated on Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1.0%
- Check42 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check49 days agoChange DetectedNew helpful links have been added, including a study on investigational dulaglutide doses for Type 2 diabetes patients on metformin monotherapy.SummaryDifference0.7%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check63 days agoChange DetectedThe website has been updated to include a new type of intervention in version 2.14.0, while the previous version 2.13.3 has removed the type of intervention and a study related to investigational Dulaglutide doses.SummaryDifference0.8%
Stay in the know with updates to Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.